PTC Therapeutics

IPO

Pioneering Rare Disease Treatments

Public · South Plainfield, United States · Founded 1998 · $216.6M raised

Employees
501–1000
Founded
1998
Business Model
B2B
Website
ptcbio.com
Total Funding
$216.6M
Last Round
$50.0M Corporate RoundOct 2022
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 6 investors for this company. The full record is or through the API.

About

PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and commercializes clinically differentiated medicines for patients living with rare diseases of high unmet need. The company's portfolio spans metabolic conditions such as PKU and familial chylomicronemia syndrome, and neurological disorders including Duchenne muscular dystrophy, Friedreich's ataxia, and Huntington's disease. PTC applies two core scientific platforms — splicing modulation and inflammation/ferroptosis targeting — to deliver transformative therapies where few or no options exist.

Summary

PTC Therapeutics is a Biotech company based in South Plainfield, United States, founded in 1998. It has raised $216.6M in total across 6 rounds, most recently a $50.0M Corporate Round in Oct 2022. Investors include Credit Suisse, J.P. Morgan and Brookside Capital Partners Fund, L.P..

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Debt FinancingDebt FinancingOct 2022
$300.0M

Sign up to see all 8 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PTC Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ptc-therapeutics"><img src="https://indexed.vc/api/badge/company/ptc-therapeutics" alt="PTC Therapeutics on Indexed.vc" width="260" height="76" /></a>